In the clinical trial, the vaccine candidates were compared to a licensed influenza vaccine and the companies' Omicron BA.4/BA.5-adapted bivalent COVID-19 ...
Gregory Poland, MD, said his tinnitus got worse after COVID infection.
The company dosed its first study participant with its investigational vaccine, mRNA-1083. And this follows recent data reported from their phase 1/2 trial ...
The combination vaccine candidates demonstrated a safety profile consistent with Pfizer's COVID-19 vaccine. A phase 3 trial is anticipated to commence in ...
Howie and Harlan discuss current issues in healthcare, including burnout at the hospital, the downsides to Medicare Advantage, and how AI is helping ...
Pfizer Inc. and BioNTech SE today announced positive topline results from a Phase 1/2 clinical study evaluating the safety, tolerability, and immunogenicity ...
GBS cases (n = 76) were identified based on hospital discharge data from January 2021 to June 2022. For every GBS case, investigators chose 10 controls at ...
Pfizer is moving ahead with the final-stage trial of its combination COVID-19 and flu vaccine candidates.
Pfizer and BioNTech announced Thursday it would soon begin a Phase 3 trial for its combined flu and COVID-19 mRNA vaccine following โpositiveโ results from ...